King Hussein Cancer Center Executive and Leadership Team

Asem Mansour, the Chief Executive Officer at King Hussein Cancer Center, directs the overarching clinical strategy and institutional growth of this premier oncology facility. Mansour manages the integration of advanced treatment protocols across the Arab world, ensuring that the center maintains its status as a leader in comprehensive cancer care. By fostering international partnerships with major global cancer centers, the Chief Executive Officer expands the reach of research initiatives and training programs. Asem Mansour coordinates with the board to align operational goals with the mission of providing high-quality care to patients of all nationalities. Through the implementation of innovative medical techniques, the Chief Executive Officer drives the organization toward improved patient survival rates. This leadership role requires constant oversight of the medical staff and the continuous refinement of institutional policies to support the complex needs of oncology patients throughout the region.

Nisreen Qatamish, the Director General - Chief Executive Officer at King Hussein Cancer Center, oversees the strategic execution of the center's mission to provide specialized oncology services. Qatamish directs the administrative and clinical alignment necessary to support over 300 specialized doctors and 1,100 oncology nurses. By focusing on community outreach and public health initiatives, the Director General - Chief Executive Officer expands the impact of the center beyond clinical walls. Nisreen Qatamish manages the development of educational programs designed to train future generations of oncology professionals. This role involves balancing the demands of patient care with the necessity of sustainable growth in a competitive medical landscape. Through rigorous oversight of institutional performance, the Director General - Chief Executive Officer ensures that the center remains at the forefront of cancer treatment innovation while maintaining the highest standards of care for every patient.

Eyad Amireh, the Chief Financial Officer at King Hussein Cancer Center, manages the fiscal health and long-term financial planning of the organization. Amireh directs the allocation of resources to support advanced treatment technologies and the expansion of clinical facilities. By analyzing revenue streams and operational costs, the Chief Financial Officer ensures the sustainability of the center's comprehensive care programs. Eyad Amireh coordinates with department heads to optimize budget utilization, allowing for the continuous improvement of oncology services. This leadership position involves securing the financial foundation necessary for the center to maintain its status as a premier medical institution in the region. Through strategic financial modeling, the Chief Financial Officer supports the growth of research and training initiatives. Amireh maintains fiscal discipline while enabling the organization to invest in the specialized equipment and personnel required to treat complex cancer cases effectively.

Muna Qadri, the Chief Financial Controller and Chief Financial Officer at King Hussein Cancer Center, oversees the integrity of financial reporting and internal audit processes. Qadri directs the implementation of robust accounting systems that track the complex expenditures associated with high-volume oncology care. By monitoring the financial performance of various clinical departments, the Chief Financial Controller and Chief Financial Officer identifies opportunities for cost efficiency and operational improvement. Muna Qadri ensures compliance with international financial standards, providing the transparency required for global partnerships and research funding. This role involves managing the financial risks inherent in operating a large-scale medical facility. Through meticulous oversight of the balance sheet, the Chief Financial Controller and Chief Financial Officer supports the strategic objectives of the center. Qadri provides the financial data necessary for the executive team to make informed decisions regarding the expansion of medical services and infrastructure.

Kais Al-Mousa, the Chief Administrative Officer (CAO) at King Hussein Cancer Center, directs the daily operational functions that support the clinical environment. Al-Mousa manages the logistics of facility management, human resources, and supply chain operations to ensure that medical teams have the necessary resources for patient care. By streamlining administrative workflows, the Chief Administrative Officer (CAO) enhances the efficiency of the center's support services. Kais Al-Mousa coordinates with the medical leadership to ensure that administrative policies align with the needs of the oncology staff and patients. This role involves overseeing the infrastructure and operational systems that allow the center to function as a leading medical hub. Through the optimization of internal processes, the Chief Administrative Officer (CAO) contributes to the overall effectiveness of the organization. Al-Mousa maintains a focus on operational excellence to support the delivery of high-quality cancer treatment across the region.

Hikmat Abdel-Razeq, the Chief Medical Officer & Deputy Director, General at King Hussein Cancer Center, directs the clinical standards and medical governance of the institution. Abdel-Razeq oversees the performance of the specialized medical staff, ensuring that all treatment protocols meet international benchmarks for oncology care. By leading the development of new clinical pathways, the Chief Medical Officer & Deputy Director, General improves the quality of care for patients of all ages. Hikmat Abdel-Razeq coordinates with the research team to integrate the latest medical findings into daily practice. This leadership role involves managing the complex medical operations that define the center's reputation for excellence. Through the supervision of clinical departments, the Chief Medical Officer & Deputy Director, General ensures that the center remains a leader in cancer treatment. Abdel-Razeq drives the medical strategy that supports the organization's commitment to fighting cancer through innovative and evidence-based techniques.